Vermont Senate Panel Previews Amendment Narrowing House-Passed Safe Drug Consumption Site Bill To Single Facility
Justice Department Is Investigating Marijuana-Related Businesses Over COVID Relief Loans, Industry Sources Say
New Hampshire Governor Indicates He Won’t Sign House-Passed Marijuana Legalization Bill Unless Senate Makes Changes
Amended Nebraska Bill Reduces Proposed Hemp And CBD Tax Rate From 100% Down To 25%
These Marijuana Companies Are Funding Florida’s Legalization Ballot Campaign, New Records Show
Medical Marijuana Patient Enrollment Grew 610% Since 2016, Showing ‘Increasing Cultural Acceptance Of Cannabis,’ Federal Study Finds
Use Of Psilocybin For Mental Health Treatment ‘Not Associated’ With Risk Of Paranoia, American Medical Association Study Finds
More Than 90% Of Smokable Hemp Samples Analyzed By Researchers Contained Illegal Amounts Of THC, New Federal Study Finds
CBD’s Potential To Treat Pain, Cancer, Schizophrenia, COVID And Other Conditions Highlighted In New Scientific Review
Teen Marijuana Use Has Declined In Washington Since Legalization, New State Research Shows
Former Minnesota Gov. Jesse Ventura Promotes New Cannabis Brand Ahead Of 4/20 That He’d ‘Offer To You’ On Governor’s Mansion Visit
Colorado Amendment Addresses Concerns On Banning Social Media Marijuana Posts, But Questions On Psychedelics And Other Drugs Remain
Former Minnesota Governor Jesse Ventura Launches His Own Cannabis Brand, Fulfilling A ‘Lifelong Dream’
Marijuana Rolling Paper Company Seeks Content Creator To ‘Get Paid To Smoke Weed’ For $70,420 Salary
Nevada’s First Marijuana Consumption Lounge Officially Opens, With Top Lawmaker Hitting A Joint At 4:20
The Legal Marijuana Industry Now Supports More Than 440,000 Full-Time Jobs, Up 5% From Last Year, Report Finds
Missouri Warns Marijuana License Applicants Of ‘Predatory Practices’ Around Social Equity Status
Missouri Marijuana Worker Union Dispute Could Have Major Implications For National Labor Law
New Mexico Retailers Set A New Marijuana Sales Record In March
Missouri Revokes Nine Marijuana Business Licenses Over Social Equity Ineligibility
Vermont Senate Panel Previews Amendment Narrowing House-Passed Safe Drug Consumption Site Bill To Single Facility
New Hampshire House Passes Bill To Legalize Marijuana Through ‘Agency Store’ Model That Senators Oppose
FDA Head Says There’s ‘No Reason For DEA To Delay’ Rescheduling Marijuana
Ohio Governor Pushes Lawmakers To Ban Public Marijuana Consumption And Delta-8 THC Products In State Of The State Speech
Pennsylvania Lawmakers Talk Marijuana Justice And Equity Issues At Hearing Following New Legalization Bill’s Introduction
FDA head tells DEA to not delay cannabis rescheduling (Newsletter: April 12, 2024)
Ohio cannabis sales could launch early (Newsletter: April 11, 2024)
Schumer cannabis legalization bill coming soon (Newsletter: April 10, 2024)
Feds seize state-licensed cannabis (Newsletter: April 9, 2024)
DOJ says legal cannabis boosts tourism (Newsletter: April 8, 2024)
Published
on
By
The Massachusetts attorney general’s office has determined that a pair of 2024 psychedelics legalization ballot initiatives have met state constitutional requirements, and it’s now releasing final summaries of the measures and allowing activists to begin collecting signatures to qualify them to go before voters next year.
In a press release on Wednesday, the office said that it vetted 42 initiative petitions and approved 34 of them, including that psychedelics reform measures that were first submitted to the state last month.
The proposals from the Massachusetts for Mental Health Options campaign are nearly identical, except that one would give adults a home grow option and the other would not. Accordingly, the final summaries largely mirror each other with that one policy distinction.
“We appreciate the Attorney General’s decision to certify both of our petitions,” the campaign said in a statement shared with Marijuana Moment on Wednesday. “We believe that Massachusetts voters should have the opportunity to expand mental health access to natural psychedelics.”
“Research from top health care organizations like Johns Hopkins and Harvard Medical School show promising results that natural psychedelics can be successful in treating anxiety, depression and PTSD. In particular, we know veterans and first responders who suffer mental health issues need more help and tools for treatment,” advocates said. “The ballot question we are proposing will offer relief and hope to those in need.”
The measures would both create a regulatory framework for lawful and medically supervised access to psychedelics at licensed facilities. Both would legalize the possession and gifting of psychedelics such as psilocybin and ayahuasca, but they would not otherwise provide for commercial retail sales of the substances.
That’s a key point that the campaign wanted to drive home as the attorney general’s office drafted the summaries. An attorney for the Massachusetts for Mental Health Options campaign urged the office to make slight revisions to initial versions to emphasize that the initiatives would not create a system like the state’s marijuana market, according to a copy of the draft that had track changes comments.
Mason Marks, a law professor at the Florida State University College of Law and co-founder of the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center at Harvard Law School, shared the draft document with Marijuana Moment last week.
“This proposed law would license and regulate facilities offering supervised use of these psychedelic substances and provide for the taxation of proceeds from those facilities’ sales of psychedelic substances,” the final summaries for both measures say.
The campaign behind the initiatives is being backed by the national New Approach PAC, which has financially supported successful psychedelics reform efforts in other states like Colorado.
Here are the key details of the Natural Psychedelic Substances Act:
Now that the attorney general has finalized the summaries, the campaign—once it decides which version of the initiative to pursue—will need to collect an initial batch of 74,574 valid signatures from registered voters and turn them into the secretary of state’s office by the first Wednesday of December.
At that point, the measure would be set to the legislature, which could choose to enact them, propose a substitute or decline to act. If lawmakers decide not to pursue the reform by the first Wednesday of May 2024, activists would then have until the first Wednesday of July to submit at least 12,429 additional valid signatures.
—
Marijuana Moment is tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
Notably, the version of the initiative that allows for home grow is being endorsed by Bay Staters for Natural Medicine (BSNM), an organization that has spearheaded a half dozen local psychedelics reform measures in the state and that previously criticized the statewide ballot campaign for a lack of consultation in the lead-up to the filing. The group is neutral on the measure that lacks a home cultivation option, however.
BSNM has helped enact local policies to deprioritize enforcement of laws against psychedelics in six cities: Salem, Somerville, Cambridge, Easthampton, Northampton and Amherst.
Meanwhile, in the Massachusetts legislature, a Republican lawmaker filed three psychedelics reform bills in April, including proposals to legalize substances like psilocybin and reschedule MDMA pending federal approval while setting a price cap on therapeutic access.
There are several other pieces of psychedelics legislation that have been introduced in Massachusetts for the session by other legislators, including separate measures to legalize certain entheogenic substances for adults.
Another bill would authorize the Department of Public Health to conduct a comprehensive study into the potential therapeutic effects of synthetic psychedelics like MDMA.
Rep. Mike Connolly (D) also filed a bill in 2021 that received a Joint Judiciary Committee hearing on studying the implications of legalizing entheogenic substances like psilocybin and ayahuasca.
Three In Five Floridians Support Marijuana Legalization, New Poll Finds As State Supreme Court Weighs 2024 Reform Ballot Initiative
Photo elements courtesy of carlosemmaskype and Apollo.
Congressman’s Interference In Cherokee Tribe’s Marijuana Legalization Vote Could Help Referendum Pass, Chief Says
Three In Five Floridians Support Marijuana Legalization, New Poll Finds As State Supreme Court Weighs 2024 Reform Ballot Initiative
Kyle Jaeger is Marijuana Moment’s Sacramento-based managing editor. His work has also appeared in High Times, VICE and attn.
Vermont Senate Panel Previews Amendment Narrowing House-Passed Safe Drug Consumption Site Bill To Single Facility
Justice Department Is Investigating Marijuana-Related Businesses Over COVID Relief Loans, Industry Sources Say
New Hampshire Governor Indicates He Won’t Sign House-Passed Marijuana Legalization Bill Unless Senate Makes Changes
Amended Nebraska Bill Reduces Proposed Hemp And CBD Tax Rate From 100% Down To 25%
These Marijuana Companies Are Funding Florida’s Legalization Ballot Campaign, New Records Show
FDA head tells DEA to not delay cannabis rescheduling (Newsletter: April 12, 2024)
All the cannabis news you need, all in one place. Copyright © 2017-2024 Marijuana Moment LLC ® and Tom Angell
Massachusetts Attorney General Clears 2024 Psychedelics Legalization Ballot Initiatives And Releases Final Summaries – Marijuana Moment
